Bank Of America Corp Crispr Therapeutics Ag Call Options Transaction History

Bank Of America Corp

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$51.17 - $68.18 $2.52 Million - $3.36 Million	-49,300 Reduced 40.78%	71,600 $3.87 Million
Q1 2024 May 15, 2024	SELL	$60.67 - $89.12 $606,700 - $891,200	-10,000 Reduced 7.64%	120,900 $8.24 Million
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $5.02 Million - $9.39 Million	130,100 Added 16262.5%	130,900 $8.19 Million
Q2 2023 Aug 14, 2023	BUY	$43.47 - $67.77 $34,776 - $54,216	800 New	800 $44,000
Q4 2021 Feb 08, 2022	SELL	$70.09 - $111.29 $4.58 Million - $7.27 Million	-65,300 Reduced 28.89%	160,700 $12.2 Million
Q3 2021 Nov 15, 2021	SELL	$110.2 - $156.64 $4.45 Million - $6.33 Million	-40,400 Reduced 15.17%	226,000 $25.3 Million
Q2 2021 Sep 13, 2021	BUY	$100.84 - $161.89 $26.9 Million - $43.1 Million	266,400 New	266,400 $43.1 Million

499

56.8M

1.7M

1.8M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.05B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.